YZi Labs Announces Investment in Regenerative Medicine Company Renewal Bio

Golden Finance reports that YZi Labs has announced an investment in the regenerative medicine company Renewal Bio. This marks YZi Labs' first biotechnology investment since expanding its investment scope in early 2025. Renewal Bio focuses on utilizing its proprietary Stembroid™ platform to generate human cells and tissues with fully matched DNA from patients' own cells, aiming to address the global organ shortage crisis. This round of funding will accelerate the preclinical development of Stembroid-derived hematopoietic stem cells for leukemia and immune disease treatments, as well as support the expansion of laboratory infrastructure.